HepaRegeniX raises €21.5M with Wellington Partners joining its investor syndicate to advance clinical trials for liver disease therapies.
Amount Raised
€21.5 Million
Round Type
Funding Round
TübingenBiotechnologyHealth CareTherapeuticsInvestors
Description
HepaRegeniX, headquartered in Germany, is a clinical-stage company focused on novel therapies for liver diseases. The company raised €21.5M to support its ongoing Phase Ib trial and advance the Phase IIa clinical trial for HRX-215. This funding round included Wellington Partners in the investor syndicate. HepaRegeniX aims to enhance treatment options for acute and chronic liver conditions.
Quick answer
HepaRegeniX GmbH raised €21.5 Million in a Funding Round round, dated April 21, 2025. Investors: Wellington Partners. HepaRegeniX GmbH is based in Tübingen, Baden-Württemberg, Germany.
- How much did HepaRegeniX GmbH raise?
- HepaRegeniX GmbH raised €21.5 Million in a Funding Round round on April 21, 2025.
- Who invested in HepaRegeniX GmbH?
- Wellington Partners is named as investors in this round.
- What does HepaRegeniX GmbH do?
- HepaRegeniX GmbH is a clinical-stage biotechnology company developing novel therapies for the treatment of acute and chronic liver diseases.
- Where is HepaRegeniX GmbH based and how big is it?
- HepaRegeniX GmbH is based in Tübingen, Baden-Württemberg, Germany.
- Who are the decision-makers at HepaRegeniX GmbH?
- Fundz holds 1 contact at HepaRegeniX GmbH. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as HepaRegeniX GmbH that raised within 45 days of this round, from Fundz verified event records.
- Gradalis raised $13M on June 5, 2025.
- Aeon raised $9.3M (Seed) on June 4, 2025.
- Renasant Bio raised $30M on June 3, 2025.
- TuHURA Biosciences raised $13M (Private Equity) on June 3, 2025.
- Vima Therapeutics raised $60M (Series A) on May 30, 2025.
- ProteinQure raised $11M (Series A) on May 28, 2025.
Who to call at HepaRegeniX GmbH, and when
A new round usually means HepaRegeniX GmbH is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day HepaRegeniX GmbH raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HepaRegeniX GmbH, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HepaRegeniX GmbH. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment HepaRegeniX GmbH raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
HepaRegeniX GmbH raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.